Fundraising FoxStellular Bio
1 known investors
Find your way into Stellular Bio
Sign up to see every warm intro you have to Stellular Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Stellular Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Stellular Bio develops platelet-derived regenerative biologic (PRB) therapeutics to treat ocular surface disease, initially targeting Sjogren's syndrome-related dry eye. The company has demonstrated efficacy in animal models and is advancing its lead candidate toward clinical testing.
Investors · 1
Frequently asked questions
- What does Stellular Bio do?
- Stellular Bio develops platelet-derived regenerative biologic (PRB) therapeutics to treat ocular surface disease, initially targeting Sjogren's syndrome-related dry eye. The company has demonstrated efficacy in animal models and is advancing its lead candidate toward clinical testing.
- Who are Stellular Bio's investors?
- Stellular Bio's investors include Qiming Venture Partners USA.